Finnish biotech company granted Singapore patent in fight against blindness

Life Biosciences Doses First Patient in FDA-Approved Gene Therapy Trial for Age-Related Blindness

Life Biosciences has dosed its first patient in an FDA-approved clinical trial testing a gene therapy designed to reverse cellular aging. Th

Life Biosciences Conducts First Gene Therapy Trial to Reverse Cellular Aging in Patient with Glaucoma

Life Biosciences, a Boston-based biotech startup, has conducted the world's first gene therapy on a living patient aimed at reversing cellul

Biotech Startup LambdaVision Uses Space Manufacturing to Develop Artificial Retinas for Blindness Treatment

LambdaVision, a biotech startup, is developing artificial retinas made from hundreds of layers of a light-activated protein called bacterior

Retinal implant invented by Stanford scientist restores limited vision to blind adults with macular degeneration

A Stanford-invented retinal implant called PRIMA, now manufactured by Science Corp. in Alameda, is restoring limited vision to blind adults

Derivation of functional retinal endothelial cells from human pluripotent stem cells for therapeutics and modelling - Nature Biomedical Engineering

US company to offer unapproved anti-ageing gene therapy at overseas clinics

An American company is planning to offer an unregulated anti-ageing gene therapy at overseas clinics outside US jurisdiction, bypassing FDA